Michael Beeton
Reader in Medical Microbiology
Cardiff School of Sport & Health Sciences
Research Publications
Disseminated Mycoplasma pneumoniae infection presenting with polyarthritis and endocarditis
Layton, G. R., Veater, J. B., Thombre, R., Afshar, B., Beeton, M. L., Ladani, S., El-Dean, Z., Stephenson, I. & Zakkar, M., 26 Mar 2025, (E-pub ahead of print) In: The Lancet Infectious Diseases. 25, 4, p. e253-e254Research output: Contribution to journal › Article › peer-review
Global spatiotemporal dynamics of Mycoplasma pneumoniae re-emergence after COVID-19 pandemic restrictions: an epidemiological and transmission modelling study
Beeton, M., On Behalf Of The European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycoplasma and Chlamydia Infections (ESGMAC) & Mycoplasma pneumoniae Surveillance (MAPS) study group, 27 Feb 2025, In: The Lancet Microbe.Research output: Contribution to journal › Article › peer-review
Broth microdilution protocol for determining antimicrobial susceptibility of Legionella pneumophila to clinically relevant antimicrobials
on behalf of the ESCMID Study Group Legionella Infections, Jan 2025, In: Journal of Microbiological Methods. 228, 107071.Research output: Contribution to journal › Article › peer-review
Mycoplasma pneumoniae: not a typical respiratory pathogen
Rowlands, R. S., Meyer Sauteur, P. M., Beeton, M. L. & On Behalf Of The Escmid Study Group For Mycoplasma And Chlamydia Infections Esgmac, 30 Oct 2024, In: Journal of Medical Microbiology. 73, 10, 001910.Research output: Contribution to journal › Article › peer-review
Miniscule Mollicutes: Current hurdles to bacteriophage identification
Catchpowle, J., Maynard, J., Chang, B. J., Payne, M. S., Beeton, M. L. & Furfaro, L. L., 2 Aug 2024, In: Sustainable Microbiology. 1, 1Research output: Contribution to journal › Review article › peer-review
Pneumonia outbreaks due to re-emergence of Mycoplasma pneumoniae
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group, 8 Feb 2024, In: The Lancet Microbe. 5, 6, p. e514Research output: Contribution to journal › Letter › peer-review
Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group, 23 Nov 2023, In: The Lancet Microbe. 5, 2, p. e100-e101Research output: Contribution to journal › Comment/debate
Mycoplasma pneumoniae: gone forever?
ESGMAC the ESGMAC MAPS study group, 29 Jun 2023, In: The Lancet Microbe. 4, 10, p. e763Research output: Contribution to journal › Letter › peer-review
A Synthetic Polymicrobial Community Biofilm Model Demonstrates Spatial Partitioning, Tolerance to Antimicrobial Treatment, Reduced Metabolism, and Small Colony Variants Typical of Chronic Wound Biofilms
Khalid, A., Cookson, A. R., Whitworth, D. E., Beeton, M. L., Robins, L. I. & Maddocks, S. E., 10 Jan 2023, In: Pathogens. 12, 1, 118.Research output: Contribution to journal › Article › peer-review
Phenotypic and genotypic antimicrobial susceptibility patterns of the emerging human respiratory pathogen Mycoplasma amphoriforme isolated from the UK and Denmark
on behalf of the ESCMID Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), 1 Sept 2022, In: Journal of Antimicrobial Chemotherapy. 77, 11, p. 3126-3129 4 p.Research output: Contribution to journal › Article › peer-review